CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-07 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +79,517 | 79,517 | ||
| 2015-08-07 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +79,517 | 79,517 | ||
| 2015-08-07 | Kummeth Charles R. Chief Executive Officer | Grant or award · Restricted Stock Unit | +11,522 | 11,522 | ||
| 2015-07-02 | Eansor Norman David SVP Biotech | Exercise or conversion | +1,667 | 1,667 | ||
| 2015-07-02 | Eansor Norman David SVP Biotech | Shares withheld for taxes | −531 | $96.54 | $51K | 1,136 |
| 2015-07-02 | Eansor Norman David SVP Biotech | Exercise or conversion · Restricted Stock Units | −1,667 | 3,333 | ||
| 2015-06-08 | STEER RANDOLPH C Director | Sale | −1,000 | $99.39 | $99K | 1,000 |
| 2015-06-08 | VERONNEAU MARCEL SVP - Clinical Controls | Shares withheld for taxes | −309 | $98.75 | $31K | 34,604 |
| 2015-06-08 | VERONNEAU MARCEL SVP - Clinical Controls | Exercise or conversion | +385 | $79.41 | $31K | 34,989 |
| 2015-06-08 | VERONNEAU MARCEL SVP - Clinical Controls | Exercise or conversion · Stock Option | −385 | 0 | ||
| 2015-03-31 | Hippel James Chief Financial Officer | Exercise or conversion | +1,666 | 1,666 | ||
| 2015-03-31 | Hippel James Chief Financial Officer | Shares withheld for taxes | −566 | $100.29 | $57K | 1,100 |
| 2015-03-31 | Hippel James Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,666 | 3,334 | ||
| 2015-02-19 | OCONNELL HOWARD V Director | Exercise or conversion | +5,000 | $56.17 | $281K | 75,000 |
| 2015-02-19 | OCONNELL HOWARD V Director | Sale | −5,000 | $95.78 | $479K | 70,000 |
| 2015-02-19 | OCONNELL HOWARD V Director | Exercise or conversion · Stock Option (right to buy) | −5,000 | 0 | ||
| 2015-02-05 | Dinarello Charles A Director | Exercise or conversion | +1,500 | $54.91 | $82K | 5,500 |
| 2015-02-05 | Dinarello Charles A Director | Exercise or conversion · Stock Option | −1,500 | 0 | ||
| 2014-12-10 | HOLBROOK KAREN A Director | Sale | −1,000 | $92.40 | $92K | 1,000 |
| 2014-12-09 | REAGAN KEVIN J Senior VP - Biotech | Exercise or conversion | +2,591 | $70.96 | $184K | 2,591 |
Page 67 of 75 · 1,487 trades